When ADHD and substance use disorders intersect: Relationship and treatment implications
There has been increasing interest in the overlap between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders (SUDs). In this report, we describe the developmental relationship between ADHD and SUDs. ADHD alone and in combination with co-occurring psychopathology is a risk factor for the development of SUDs in adulthood. Conversely, approximately one fifth of adults with SUDs have ADHD. Pharmacotherapeutic treatment of ADHD in children reduces the risk for later cigarette smoking and SUDs in adulthood. In contrast, medication treatment alone of adults with ADHD and current SUD is inadequate for both ADHD and SUD. Stimulant diversion continues to be of concern, particularly in older adolescents and young adults.
KeywordsCocaine Bupropion Atomoxetine Acad Child Adolesc Psychiatry Lisdexamfetamine
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 19.Katusic SK, Barbaresi WJ, Colligan RC, et al.: Substance abuse among ADHD cases: a population-based birth cohort study. Paper presented at the Pediatric Academic Society. Seattle, WA; May 3–6, 2003.Google Scholar
- 23.Monuteaux MC, Spencer TJ, Faraone SV, et al.: A randomized clinical trial of bupropion for the prevention of smoking in youth with attention-deficit hyperactivity disorder. J Clin Psychiatry 2007, In press.Google Scholar
- 37.McDermott SP, Wilens TE: Cognitive therapy for adults with ADHD. In Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults. Edited by Brown T. Washington, DC: American Psychiatric Press; 2000:569–606.Google Scholar
- 44.Brady KT, Wilens TE, Adler LA, et al.: Atomoxetine treatment of adults with ADHD and comorbid alcohol abuse disorder. Paper presented at the 45th Annual Meeting of the American College of Neuropsychopharmacology. Hollywood, FL; December 3–7, 2006.Google Scholar
- 48.Spencer T, Biederman J, Ciccone P, et al.: A PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short and long-acting orally administered formulations of methylphenidate in adults. Am J Psychiatry 2006, 163:387–395.PubMedCrossRefGoogle Scholar
- 50.Poulin C: Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CM AJ 2001, 165:1039–1044.Google Scholar